Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine
نویسندگان
چکیده
منابع مشابه
John Charnley Award: Preoperative Patient-reported Outcome Measures Predict Clinically Meaningful Improvement in Function After THA
BACKGROUND Despite the overall effectiveness of total hip arthroplasty (THA), a subset of patients remain dissatisfied with their results because of persistent pain or functional limitations. It is therefore important to develop predictive tools capable of identifying patients at risk for poor outcomes before surgery. QUESTIONS/PURPOSES The purpose of this study was to use preoperative patien...
متن کاملMeaningful outcome measures in cardiac surgery.
The most common cardiac surgical procedures are coronary artery bypass graft surgery and aortic or mitral valve repair or replacement. Underlying conditions include coronary artery disease and heart failure, manifesting as exertional angina, dyspnea, and poor exercise tolerance. The major goals of surgery are to alleviate symptoms and improve patient survival. These, therefore, should inform th...
متن کاملSustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function
OBJECTIVE The aim of this study was to determine the efficacy of sustained-release fampridine (4-aminopyridine) in veterans with multiple sclerosis (MS) with limited ambulatory ability, and its impact on motor function in an outpatient setting. DESIGN Retrospective. SETTING Tertiary referral center [Veterans Affairs (VA) Medical Center]. PARTICIPANTS Veterans; 20 MS patients were prescrib...
متن کاملSustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
BACKGROUND Clinical studies suggested that fampridine (4-aminopyridine) improves motor function in people with multiple sclerosis. This phase III study assessed efficacy and safety of oral, sustained-release fampridine in people with ambulatory deficits due to multiple sclerosis. METHODS We undertook a randomised, multicentre, double-blind, controlled phase III trial. We randomly assigned 301...
متن کاملDynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine)
BACKGROUND Impaired walking capacity is a frequent confinement in Multiple Sclerosis (MS). Patients are affected by limitations in coordination, walking speed and the distance they may cover. Also abnormal dynamic walking patterns have been reported, involving continuous deceleration over time. Fampridine (4-aminopyridine), a potassium channel blocker, may improve walking in MS. The objective o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutic Advances in Neurological Disorders
سال: 2018
ISSN: 1756-2864,1756-2864
DOI: 10.1177/1756286418780007